Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Labcorp Holdings Inc.
Labcorp Holdings Inc. News
Labcorp Holdings Inc. Quantitative Score
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Labcorp Holdings Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Labcorp Holdings Inc. Financials
Table Compare
Compare LH metrics with: | |||
|---|---|---|---|
Earnings & Growth | LH | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | LH | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | LH | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | LH | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Labcorp Holdings Inc. Income
Labcorp Holdings Inc. Balance Sheet
Labcorp Holdings Inc. Cash Flow
Labcorp Holdings Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Labcorp Holdings Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 2.8800 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-12-11 | 0.72 | Quarterly |
| 2025-09-11 | 0.72 | Quarterly |
| 2025-06-11 | 0.72 | Quarterly |
| 2025-03-12 | 0.72 | Quarterly |
| 2024-12-13 | 0.72 | Quarterly |
Historical Market Cap
Shares Outstanding
Labcorp Holdings Inc. Executives
| Name | Role |
|---|---|
| Mr. Adam H. Schechter | President, Chief Executive Officer & Chairman |
| Ms. Anita Z. Graham | Executive Vice President & Chief Human Resources Officer |
| Mr. Mark S. Schroeder | Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer |
| Dr. Brian J. Caveney J.D., M.D., M.P.H. | EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer |
| Ms. Julia A. Wang | Chief Financial Officer & Executive Vice President |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Adam H. Schechter | President, Chief Executive Officer & Chairman | Male | 1965 | 4.15M |
| Ms. Anita Z. Graham | Executive Vice President & Chief Human Resources Officer | Female | 1971 | 1.58M |
| Mr. Mark S. Schroeder | Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer | Male | 1961 | 1.46M |
| Dr. Brian J. Caveney J.D., M.D., M.P.H. | EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | 1974 | 1.29M | |
| Ms. Julia A. Wang | Chief Financial Officer & Executive Vice President | Female | 1972 | 669.36K |
Labcorp Holdings Inc. Insider Trades
| Date | 11 Nov |
| Name | Schechter Adam H |
| Role | President & CEO |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 5745 |
| Date | 1 Nov |
| Name | Bailey Megan D. |
| Role | EVP, Pres, Central Labs & Intl |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 370 |
| Date | 3 Nov |
| Name | Bailey Megan D. |
| Role | EVP, Pres, Central Labs & Intl |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 179 |
| Date | 1 Nov |
| Name | Bailey Megan D. |
| Role | EVP, Pres, Central Labs & Intl |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 370 |
| Date | 1 Nov |
| Name | Oyegunwa Akinbolade |
| Role | EVP, CIO & CTO |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 370 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 11 Nov | Schechter Adam H | President & CEO | Disposed | S-Sale | 5745 |
| 1 Nov | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Acquired | M-Exempt | 370 |
| 3 Nov | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Disposed | F-InKind | 179 |
| 1 Nov | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Disposed | M-Exempt | 370 |
| 1 Nov | Oyegunwa Akinbolade | EVP, CIO & CTO | Acquired | M-Exempt | 370 |